title: Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors.
authors.affiliation: Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain - Christian.Rolfo@uza.be.
authors.forename: J P
authors.initials: JP
authors.lastname: Fusco
authors.forename: C
authors.initials: C
authors.lastname: Rolfo
authors.forename: E
authors.initials: E
authors.lastname: Castañón
authors.forename: L
authors.initials: L
authors.lastname: Ceniceros
authors.forename: J
authors.initials: J
authors.lastname: Legaspi
authors.forename: J
authors.initials: J
authors.lastname: Espinós
authors.forename: J
authors.initials: J
authors.lastname: Rodríguez
authors.forename: J M
authors.initials: JM
authors.lastname: Aramendía
authors.forename: M
authors.initials: M
authors.lastname: Santisteban
authors.forename: I
authors.initials: I
authors.lastname: Gil-Bazo
mesh_terms: D061605:Administration, Intravenous / Q000379:methods; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D057176:Compassionate Use Trials / Q000379:methods; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; C401859:temsirolimus; D020123:Sirolimus